Avon looks into allegations in China
This article was originally published in The Rose Sheet
Avon notifies Securities and Exchange Commission and U.S. Department of Justice that it is conducting voluntary internal investigation of its China operations, under the oversight of its Audit Committee, with focus on compliance with Foreign Corrupt Practices Act, according to Oct. 20 release. Investigation launched in June following receipt of allegation that "certain travel, entertainment and other expenses may have been improperly incurred in connection with the company's China operations," firm says. "Investigation is in its early stage, and no conclusion can be drawn at this time as to its outcome," says Avon
You may also be interested in...
Avon has suspended four of its executives - three with ties to its operations in China, as well as the company's VP-global finance - in connection with an internal investigation into alleged violations of the U.S. Foreign Corrupt Practices Act
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.